Ponatinib | Market Exclusivity | US | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Ponatinib
U.S. EXCLUSIVITIES

Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.

Contact Supplier

AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

Contact Supplier

ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

Ponatinib

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

11 API Suppliers, 3 USDMF, 3 EU WC, 4 NDC API, 7 Listed Suppliers, $ API Reference Price

11 API Suppliers
3 USDMF
3 EU WC
4 NDC API
7 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

6 Drugs in Development

6 Drugs in Development

INTERMEDIATES

2 Intermediates Suppliers

2 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

23 FDF Dossiers, 6 FDA Orange Book, 10 Europe, 1 Canada, 6 Australia

23 FDF Dossiers
6 FDA Orange Book
10 Europe
1 Canada
6 Australia

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - EQ 10MG BASE, TABLET;ORAL - EQ 15MG BASE, TABLET;ORAL - EQ 30MG BASE, TABLET;ORAL - EQ 45MG BASE

TABLET;ORAL - EQ 10MG BASE
TABLET;ORAL - EQ 15MG BASE
TABLET;ORAL - EQ 30MG BASE
TABLET;ORAL - EQ 45MG BASE

RELATED EXCIPIENT COMPANIES

1 SPI Pharma, 1 DKSH, 8 Gangwal Healthcare, 1 Nanjing Well Pharmaceutical, 3 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 4 DFE Pharma, 4 Gangwal Chemicals, 1 Ideal Cures Pvt Ltd, 17 Kerry, 9 Microlex e.U, 1 Pharmatrans-Sanaq, 2 Pluviaendo, 2 Prachin Chemical, 7 Roquette, 2 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 9 Sigachi Industries, 2 Vasa Pharmachem

1 SPI Pharma
1 DKSH
8 Gangwal Healthcare
1 Nanjing Well Pharmaceutical
3 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd
4 DFE Pharma
4 Gangwal Chemicals
1 Ideal Cures Pvt Ltd
17 Kerry
9 Microlex e.U
1 Pharmatrans-Sanaq
2 Pluviaendo
2 Prachin Chemical
7 Roquette
2 Shanghai Shenmei Pharmaceutical Technology Co., Ltd
9 Sigachi Industries
2 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

39 Fillers, Diluents & Binders, 18 Direct Compression, 11 Lubricants & Glidants, 11 Co-Processed Excipients, 11 Thickeners and Stabilizers, 8 Granulation, 5 Disintegrants & Superdisintegrants, 4 Controlled & Modified Release, 3 Emulsifying Agents, 2 Chewable & Orodispersible Aids, 2 Coating Systems & Additives, 2 Taste Masking, 1 Rheology Modifiers, 1 Parenteral, 1 Film Formers & Plasticizers, 1 API Stability Enhancers

39 Fillers, Diluents & Binders
18 Direct Compression
11 Lubricants & Glidants
11 Co-Processed Excipients
11 Thickeners and Stabilizers
8 Granulation
5 Disintegrants & Superdisintegrants
4 Controlled & Modified Release
3 Emulsifying Agents
2 Chewable & Orodispersible Aids
2 Coating Systems & Additives
2 Taste Masking
1 Rheology Modifiers
1 Parenteral
1 Film Formers & Plasticizers
1 API Stability Enhancers

DIGITAL CONTENT

1 DATA COMPILATION #PharmaFlow, 1 STOCK RECAP #PipelineProspector, 34 NEWS #PharmaBuzz

1 DATA COMPILATION #PharmaFlow
1 STOCK RECAP #PipelineProspector
34 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 7 Finished Drug Prices, 8 Annual Reports

1 US Medicaid Prescriptions
7 Finished Drug Prices
8 Annual Reports

MARKET PLACE

4 APIs, 2 FDF Dossiers

4 APIs
2 FDF Dossiers

PATENTS & EXCLUSIVITIES

68 US Patents, 8 US Exclusivities, 2 Health Canada Patents

68 US Patents
8 US Exclusivities
2 Health Canada Patents

$ API Ref.Price (USD/KG) : 140,104 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Name Reset all filters

8 All

01 8TAKEDA PHARMS USA

filter Product Reset all filters

8 All

01 8PONATINIB HYDROCHLORIDE

filter Exclusivity Expiration Date Reset all filters

8 All

01 42027-03-19

02 42031-03-19

filter Exclusivity Code Reset all filters

8 All

01 4I-934

02 4ODE-472

Product Main Page

TAKEDA PHARMS USA

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

PONATINIB HYDROCHLORIDE

Portfolio PDF

Product Web Link

Digital Content

Exclusivity Code

ODE-472

Exclusivity Expiration Date

2031-03-19

Application Number

203469

Product Number

1

Exclusivity Details

01

TAKEDA PHARMS USA

PONATINIB HYDROCHLORIDE

2024 ACI Convention

Not Confirmed

TAKEDA PHARMS USA

Japan

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

PONATINIB HYDROCHLORIDE

Exclusivity Code : ODE-472

Exclusivity Expiration Date : 2031-03-19

Application Number : 203469

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

TAKEDA PHARMS USA

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

PONATINIB HYDROCHLORIDE

Portfolio PDF

Product Web Link

Digital Content

Exclusivity Code

I-934

Exclusivity Expiration Date

2027-03-19

Application Number

203469

Product Number

1

Exclusivity Details

02

TAKEDA PHARMS USA

PONATINIB HYDROCHLORIDE

2024 ACI Convention

Not Confirmed

TAKEDA PHARMS USA

Japan

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

PONATINIB HYDROCHLORIDE

Exclusivity Code : I-934

Exclusivity Expiration Date : 2027-03-19

Application Number : 203469

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

TAKEDA PHARMS USA

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

PONATINIB HYDROCHLORIDE

Portfolio PDF

Product Web Link

Digital Content

Exclusivity Code

ODE-472

Exclusivity Expiration Date

2031-03-19

Application Number

203469

Product Number

4

Exclusivity Details

03

TAKEDA PHARMS USA

PONATINIB HYDROCHLORIDE

2024 ACI Convention

Not Confirmed

TAKEDA PHARMS USA

Japan

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

PONATINIB HYDROCHLORIDE

Exclusivity Code : ODE-472

Exclusivity Expiration Date : 2031-03-19

Application Number : 203469

Product Number : 4

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

TAKEDA PHARMS USA

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

PONATINIB HYDROCHLORIDE

Portfolio PDF

Product Web Link

Digital Content

Exclusivity Code

I-934

Exclusivity Expiration Date

2027-03-19

Application Number

203469

Product Number

4

Exclusivity Details

04

TAKEDA PHARMS USA

PONATINIB HYDROCHLORIDE

2024 ACI Convention

Not Confirmed

TAKEDA PHARMS USA

Japan

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

PONATINIB HYDROCHLORIDE

Exclusivity Code : I-934

Exclusivity Expiration Date : 2027-03-19

Application Number : 203469

Product Number : 4

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

TAKEDA PHARMS USA

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

PONATINIB HYDROCHLORIDE

Portfolio PDF

Product Web Link

Digital Content

Exclusivity Code

ODE-472

Exclusivity Expiration Date

2031-03-19

Application Number

203469

Product Number

3

Exclusivity Details

05

TAKEDA PHARMS USA

PONATINIB HYDROCHLORIDE

2024 ACI Convention

Not Confirmed

TAKEDA PHARMS USA

Japan

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

PONATINIB HYDROCHLORIDE

Exclusivity Code : ODE-472

Exclusivity Expiration Date : 2031-03-19

Application Number : 203469

Product Number : 3

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

TAKEDA PHARMS USA

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

PONATINIB HYDROCHLORIDE

Portfolio PDF

Product Web Link

Digital Content

Exclusivity Code

I-934

Exclusivity Expiration Date

2027-03-19

Application Number

203469

Product Number

3

Exclusivity Details

06

TAKEDA PHARMS USA

PONATINIB HYDROCHLORIDE

2024 ACI Convention

Not Confirmed

TAKEDA PHARMS USA

Japan

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

PONATINIB HYDROCHLORIDE

Exclusivity Code : I-934

Exclusivity Expiration Date : 2027-03-19

Application Number : 203469

Product Number : 3

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

TAKEDA PHARMS USA

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

PONATINIB HYDROCHLORIDE

Portfolio PDF

Product Web Link

Digital Content

Exclusivity Code

ODE-472

Exclusivity Expiration Date

2031-03-19

Application Number

203469

Product Number

2

Exclusivity Details

07

TAKEDA PHARMS USA

PONATINIB HYDROCHLORIDE

2024 ACI Convention

Not Confirmed

TAKEDA PHARMS USA

Japan

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

PONATINIB HYDROCHLORIDE

Exclusivity Code : ODE-472

Exclusivity Expiration Date : 2031-03-19

Application Number : 203469

Product Number : 2

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

TAKEDA PHARMS USA

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

PONATINIB HYDROCHLORIDE

Portfolio PDF

Product Web Link

Digital Content

Exclusivity Code

I-934

Exclusivity Expiration Date

2027-03-19

Application Number

203469

Product Number

2

Exclusivity Details

08

TAKEDA PHARMS USA

PONATINIB HYDROCHLORIDE

2024 ACI Convention

Not Confirmed

TAKEDA PHARMS USA

Japan

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

PONATINIB HYDROCHLORIDE

Exclusivity Code : I-934

Exclusivity Expiration Date : 2027-03-19

Application Number : 203469

Product Number : 2

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?